DDr. Eppard is radiochemist working on the development and process implementation of new compounds for theranostic application. In 2013 she obtained her Ph.D. at the Institute of Nuclear Chemistry at the JGU Mainz in the group of Prof. Rösch where she worked on radiometal based radiopharmaceuticals. After 4 years in the Department of Nuclear Medicine of the University Hospital Bonn as junior research group leader she joined Positronpharma SA in Santiago, Chile as senior scientist in 2018. There she was responsible for research and clinical applications based on 68Ga-, 44Sc- & 177Lu-labelled theranostics. Since 2021 she is radiochemist in the Department of Nuclear Medicine of the University Hospital Magdeburg where she is continuing her research.